Displaying drugs 15201 - 15225 of 15259 in total
IMIDAZOPYRIDAZIN 1
Experimental
ING-1
ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational
Amitifadine
Investigational
Zanapezil
Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational
Albaconazole
Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational
Oxyfedrine
Experimental
Methoxyamine
Investigational
R450
R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational
R-348
Investigational
7-Nitroindazole-2-Carboxamidine
Experimental
5-Nitroindazole
Experimental
2-[1-METHYLHEXYL]-4,6-DINITROPHENOL
Experimental
P-Nitrophenol
Experimental
3-(4-nitrophenyl)-1H-pyrazole
Experimental
KB002
KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Investigational
FavId
FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational
Displaying drugs 15201 - 15225 of 15259 in total